Literature DB >> 24265525

Prospective observation of 5-year clinical course of subclinical hypothyroidism in korean population.

Woo Ri Park1, Tae Keun Oh, Hyun Jeong Jeon.   

Abstract

Subclinical hypothyroidism (SCH) is a common clinical condition, whereas it's natural course has not been identified distinctly. We evaluated the natural history of 169 SCH patients over 5-yr and the prognostic factors including thyroid autoantibodies and thyroid ultrasonographic (USG) findings related to develop overt hypothyroidism. After 5 yr, 47.3% of patients showed normalization of TSH, while 36.7% of patients remained persistence of high level of TSH, and overt hypothyroidism developed in 11.2% of patients. There were painless thyroiditis (2.9%) and hyperthyroidism (1.7%) during 5 yr follow-up. The thyroid nodule was seen in 48.6% of patients. Most of patients had 1 to 2 nodules whereas only 3% of patients with thyroid nodule had more than 6 nodules. Overt hypothyroidism patients had more heterogenous echogenecity in USG compared to patients with normalization or persistent SCH (76.5% vs 50.0% vs 35.0%, P = 0.048) and higher prevalence positive anti-thyroid peroxidase (anti-TPO Ab) and anti-thyroglobulin antibody (anti-Tg Ab) and titer of anti-TPO Ab than other two groups. The cut off values for prediction of overt hypothyroidism were TSH > 7.45 µIU/mL, free T4 < 1.09 ng/dL and Anti-TPO Ab > 560 IU/mL. SCH has various courses and initial TSH, free T4, presence of thyroid autoantibody, titer of thyroid autoantibody; and thyroid USG findings can serve as a prognostic factor for progression of overt hypothyroidism. These parameters suggest consideration to initiate thyroid hormone treatment in SCH.

Entities:  

Keywords:  Hypothyroidism; Natural History; Subclinical Hypothyroidism

Mesh:

Substances:

Year:  2013        PMID: 24265525      PMCID: PMC3835504          DOI: 10.3346/jkms.2013.28.11.1622

Source DB:  PubMed          Journal:  J Korean Med Sci        ISSN: 1011-8934            Impact factor:   2.153


  21 in total

Review 1.  Clinical practice. Subclinical hypothyroidism.

Authors:  D S Cooper
Journal:  N Engl J Med       Date:  2001-07-26       Impact factor: 91.245

Review 2.  Subclinical hypothyroidism is mild thyroid failure and should be treated.

Authors:  M T McDermott; E C Ridgway
Journal:  J Clin Endocrinol Metab       Date:  2001-10       Impact factor: 5.958

Review 3.  Clinical review 115: effect of thyroxine therapy on serum lipoproteins in patients with mild thyroid failure: a quantitative review of the literature.

Authors:  M D Danese; P W Ladenson; C L Meinert; N R Powe
Journal:  J Clin Endocrinol Metab       Date:  2000-09       Impact factor: 5.958

4.  A double-blind cross-over 12-month study of L-thyroxine treatment of women with 'subclinical' hypothyroidism.

Authors:  E Nyström; K Caidahl; G Fager; C Wikkelsö; P A Lundberg; G Lindstedt
Journal:  Clin Endocrinol (Oxf)       Date:  1988-07       Impact factor: 3.478

5.  Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study.

Authors:  A E Hak; H A Pols; T J Visser; H A Drexhage; A Hofman; J C Witteman
Journal:  Ann Intern Med       Date:  2000-02-15       Impact factor: 25.391

6.  Risk for progression to overt hypothyroidism in an elderly Japanese population with subclinical hypothyroidism.

Authors:  Misa Imaizumi; Nobuko Sera; Ikuko Ueki; Ichiro Horie; Takao Ando; Toshiro Usa; Shinichiro Ichimaru; Eiji Nakashima; Ayumi Hida; Midori Soda; Tan Tominaga; Kiyoto Ashizawa; Renju Maeda; Shigenobu Nagataki; Masazumi Akahoshi
Journal:  Thyroid       Date:  2011-08-30       Impact factor: 6.568

7.  L-Thyroxine therapy in subclinical hypothyroidism. A double-blind, placebo-controlled trial.

Authors:  D S Cooper; R Halpern; L C Wood; A A Levin; E C Ridgway
Journal:  Ann Intern Med       Date:  1984-07       Impact factor: 25.391

8.  Prospective study of the spontaneous course of subclinical hypothyroidism: prognostic value of thyrotropin, thyroid reserve, and thyroid antibodies.

Authors:  Gerold Huber; Jean-Jacques Staub; Christian Meier; Cristina Mitrache; Merih Guglielmetti; Peter Huber; Lewis E Braverman
Journal:  J Clin Endocrinol Metab       Date:  2002-07       Impact factor: 5.958

9.  Current controversies in endocrinology: screening of asymptomatic elderly for subclinical hypothyroidism.

Authors:  Nina J Karlin; Nancy Weintraub; Inder J Chopra
Journal:  J Am Med Dir Assoc       Date:  2004 Sep-Oct       Impact factor: 4.669

Review 10.  Subclinical thyroid disease: scientific review and guidelines for diagnosis and management.

Authors:  Martin I Surks; Eduardo Ortiz; Gilbert H Daniels; Clark T Sawin; Nananda F Col; Rhoda H Cobin; Jayne A Franklyn; Jerome M Hershman; Kenneth D Burman; Margo A Denke; Colum Gorman; Richard S Cooper; Neil J Weissman
Journal:  JAMA       Date:  2004-01-14       Impact factor: 56.272

View more
  3 in total

1.  Natural history of subclinical hypothyroidism and prognostic factors for the development of overt hypothyroidism: Tehran Thyroid Study (TTS).

Authors:  A Amouzegar; M Dehghani; H Abdi; L Mehran; S Masoumi; F Azizi
Journal:  J Endocrinol Invest       Date:  2022-08-04       Impact factor: 5.467

2.  Comparison of Five Different Criteria for Diagnosis of Subclinical Hypothyroidism in a Large-Scale Chinese Population.

Authors:  Yan-Song Zheng; Sheng-Yong Dong; Yan Gong; Jia-Hong Wang; Fei Wang; Qiang Zeng
Journal:  Front Endocrinol (Lausanne)       Date:  2022-02-15       Impact factor: 5.555

3.  Association of longitudinal changes in serum lipids with the natural history of subclinical hypothyroidism: A retrospective cohort study using data from the REACTION study.

Authors:  Fang Zhong; Qingbo Guan; Haiqing Zhang; Xu Zhang; Meng Zhao; Zhongshang Yuan; Xiude Fan; Junming Han; Qihang Li; Zhixiang Wang; Shanshan Shao; Jiajun Zhao
Journal:  EClinicalMedicine       Date:  2022-08-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.